22-39225716-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_002608.4(PDGFB):c.*7C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000344 in 1,612,800 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 1 hom. )
Consequence
PDGFB
NM_002608.4 3_prime_UTR
NM_002608.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.381
Genes affected
PDGFB (HGNC:8800): (platelet derived growth factor subunit B) This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 22-39225716-G-A is Benign according to our data. Variant chr22-39225716-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3048695.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000256 (39/152272) while in subpopulation NFE AF= 0.000529 (36/68018). AF 95% confidence interval is 0.000392. There are 0 homozygotes in gnomad4. There are 10 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDGFB | NM_002608.4 | c.*7C>T | 3_prime_UTR_variant | 6/7 | ENST00000331163.11 | ||
PDGFB | NM_033016.3 | c.*7C>T | 3_prime_UTR_variant | 6/7 | |||
PDGFB | XM_047441393.1 | c.*7C>T | 3_prime_UTR_variant | 6/7 | |||
PDGFB | XM_047441394.1 | c.*7C>T | 3_prime_UTR_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDGFB | ENST00000331163.11 | c.*7C>T | 3_prime_UTR_variant | 6/7 | 1 | NM_002608.4 | P1 | ||
PDGFB | ENST00000381551.8 | c.*7C>T | 3_prime_UTR_variant | 6/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000199 AC: 50AN: 250650Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135494
GnomAD3 exomes
AF:
AC:
50
AN:
250650
Hom.:
AF XY:
AC XY:
24
AN XY:
135494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000353 AC: 515AN: 1460528Hom.: 1 Cov.: 31 AF XY: 0.000355 AC XY: 258AN XY: 726490
GnomAD4 exome
AF:
AC:
515
AN:
1460528
Hom.:
Cov.:
31
AF XY:
AC XY:
258
AN XY:
726490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74454
GnomAD4 genome
AF:
AC:
39
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PDGFB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at